Replacement of Left Upper Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
New Technology·Skin, Subcutaneous Tissue, Fascia and Breast·Table XHR·FY 2027
ICD-10-PCS classifies this procedure as XHR5XGA: Replacement of Left Upper Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10. Table XHR, part of Section X (New Technology) contains it. The procedure targets the Skin, Subcutaneous Tissue, Fascia and Breast body system. The approach used is External.
Advertisements
What the code means
Replacement: root operation
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
External: approach
Procedures performed directly on the skin or mucous membrane and procedures performed indirectly by the application of external force through the skin or mucous membrane
Nearby codes in table XHR
- Previous: XHR4XGA Replacement of Right Upper Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
- Next: XHR6XGA Replacement of Right Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10